Cargando…
Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality worldwide. It is a highly heterogeneous disease with poor prognosis and limited treatment options, which highlights the need for reliable biomarkers. This study aims to explore molecular markers that a...
Autores principales: | Pallerla, Srinivas Reddy, Hoan, Nghiem Xuan, Rachakonda, Sivaramakrishna, Meyer, Christian G., Van Tong, Hoang, Toan, Nguyen Linh, Linh, Le Thi Kieu, Giang, Dao Phuong, Kremsner, Peter G., Bang, Mai Hong, Song, Le Huu, Velavan, Thirumalaisamy P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641913/ https://www.ncbi.nlm.nih.gov/pubmed/36345011 http://dx.doi.org/10.1186/s12920-022-01386-7 |
Ejemplares similares
-
Interferon-stimulated gene 15 in hepatitis B-related liver diseases
por: Hoan, Nghiem Xuan, et al.
Publicado: (2016) -
Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma
por: Binh, Mai Thanh, et al.
Publicado: (2020) -
SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B
por: Hoan, Nghiem Xuan, et al.
Publicado: (2017) -
Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression
por: Hoan, Nghiem Xuan, et al.
Publicado: (2021) -
Author Correction: Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression
por: Hoan, Nghiem Xuan, et al.
Publicado: (2022)